Skip to main content
Abbott8-K: CEO change

Daniel Salvadori named Chief Executive Officer of new independent Nutrition company

What happened

Daniel Salvadori, Abbott's executive vice president and group president of Established Pharmaceuticals and Nutritional Products, will become CEO of the newly spun-off Nutrition company.

Source

SEC EDGAROct 21, 2026

Current report (Form 8-K)

Abbott 8-K

Filing excerpt

Daniel Salvadori, executive vice president and group president, Established Pharmaceuticals and Nutritional Products, will become chief executive officer of the new Nutrition company.

sec.gov/Archives/edgar/data/1800/000110465926117587/tm2627971d1_8k.htmRead the full source

Other signals in this filing (2)

Extracted by Autobound

From the Signal API record
Signal
8-K: CEO change

What this signalsA new leader often reviews the tools the team uses.

Form
8-K
Filed
Oct 21, 2026

More 8-K signals at other companies

The full record

From the Signal API record

Details

CIK
1800
Accession number
0001104659-26-117587
Filing year
2026
Why it matters
Full vendor review - highest priority
Signal category
Leadership

Extraction

Confidence
High
Relevance
90%
Sentiment
Positive
Detected
Oct 27, 2026
signal_type
sec-8k
signal_subtype
ceoChange

Use this data

Get every 8-K signal for Abbott and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Abbott this week?”

  2. Send it to your own tools

    The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/98e7f18a-71d8-459b-8591-deefa8c6deab returns this record as JSON. POST /v1/companies/enrich returns every signal for abbott.com.

{
  "signal_id": "98e7f18a-71d8-459b-8591-deefa8c6deab",
  "signal_type": "sec-8k",
  "signal_subtype": "ceoChange",
  "detected_at": "2026-10-27T08:04:13.474+00:00",
  "company": {
    "name": "Abbott",
    "domain": "abbott.com"
  },
  "data": {
    "detail": "Daniel Salvadori, Abbott's executive vice president and group president of Established Pharmaceuticals and Nutritional Products, will become CEO of the newly spun-off Nutrition company. New leadership teams establishing a standalone entity often review and replace enterprise vendor relationships within the first 90 days.",
    "summary": "Daniel Salvadori named Chief Executive Officer of new independent Nutrition company",
    "excerpts": "Daniel Salvadori, executive vice president and group president, Established Pharmaceuticals and Nutritional Products, will become chief executive officer of the new Nutrition company.",
    "relevance": 0.9,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1800/000110465926117587/tm2627971d1_8k.htm",
    "filing_date": "2026-10-21",
    "filing_year": 2026,
    "sales_relevance": "Full vendor review - highest priority",
    "signal_category": "leadership"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.